Issue Title Abstract File
No 13S (2018) 2017 Events (from open information sources) Abstract PDF
(Rus)
Article E.
No 9 (2020) 3D printing in pharmacy Abstract PDF
(Rus)
Prozherina Y.
No 9 (2020) A breakthrough in the treatment of chronic lymphocytic leukemia Abstract PDF
(Rus)
Prozherina Y., Shirokova I.
No 1-3 (2020) A comparative characteristic of business models of leading pharmaceutical manufacturers: aspects of commercial activities Abstract PDF
(Rus)
Yasinskaya L.E., Trofimova E.O.
No 4-6 (2020) A comparative characteristic of business models of leading pharmaceutical manufacturers: aspects of investment activities Abstract PDF
(Rus)
Yasinskaya L.E.
No 2 (2021) A current approach to the treatment of ulcerative colitis: updated recommendations of the American Gastroenterological Association Abstract PDF
(Rus)
Vodovozov A.
No 3 (2018) A new step in the treatment of «king's diseases» Abstract PDF
(Rus)
Shirokova I., Prozherina J.
No 1 (2022) A rational approach to the issue of responsible self-treatment through the prism of pharmaceutical counseling Abstract
Oleinikova T.A., Baribina E.S.
No 2 (2021) A review of tender purchases of L01 group – antineoplastic agents Abstract PDF
(Rus)
Kalinina N.
No 3 (2021) A structural analysis of sales of drugs for the treatment of chronic hepatitis C in the Russian market Abstract PDF
(Rus)
Tsitlionok E.A., Narkevich I.A., Nemyatykh O.D., Siukaeva D.D., Grinyuk A.S., Lisachenko V.O.
No 4 (2019) A STUDY OF FACTORS INFLUENCING PHARMACEUTICAL COUNSELING IN VIETNAMESE COMMUNITY PHARMACIES Abstract PDF
(Rus)
Dorofeeva V.V., Tran V.D.
No 1 (2022) Activities of municipalities in the field of drug provision of the population in Russia in the second half of the XIX - early XX century Abstract
Sherstneva E.V., Egorysheva I.V.
No 4-6 (2020) Advances in synthetic biology and regulatory policy of the state Abstract PDF
(Rus)
Mokhov A.A., Chaplenko A.A., Yavorskiy A.N.
No 12 (2018) Advertising in the pharm market: evaluation of 2018 practice and forecasts for self-regulation Abstract PDF
(Rus)
Borzova M.
No 12 (2019) Advertising of prescription drugs: when you can’t have everything and even more Abstract PDF
(Rus)
Borzova M.
No 11 (2019) Ad\"yuvanty - nastoyashchee i budushchee vaktsin Abstract PDF
(Rus)
Shirokova I.
No 11-12 (2020) Affordable and modern antithrombotic therapy for atrial fibrillation Abstract PDF
(Rus)
Kalinina N.
No 11-12 (2020) Agile stockpiles an insurance for drug supply Abstract PDF
(Rus)
Gilissen E., Mulligan C., Tottman S., Troein P.
No 11 (2018) Aleksandr Ametov: instrumentom importozameshcheniya dolzhen stat' gosudarstvennyy registr sakharnogo diabeta Abstract PDF
(Rus)
Article E.
No 7-8 (2020) Aleksandr TIKhOMIROV: «Nuzhno nachinat' lechenie kak mozhno ran'she, chtoby potom ne «dogonyat'» tyazheluyu voskhodyashchuyu infektsiyu» Abstract PDF
(Rus)
Article E.
No 10 (2020) Ambulatornye patsienty s koronavirusom poluchat favipiravir besplatno Abstract PDF
(Rus)
Article E.
No 5 (2019) Analysis of compliance with the rules of vacation prescription medicines from pharmacies Abstract PDF
(Rus)
Moroz T.L., Ryzhova O.A.
No 7-8 (2020) Analysis of current issues for development of pharmaceutical products export in the russian federation: the case of biotechnology enterprise Abstract PDF
(Rus)
Trukhin V.P., Narkevich I.A., Nacharova E.P., Basakina I.I., Poliakova I.N.
No 5 (2018) Analysis of development trends of the pharmaceutical market of non-steroidal anti-inflammatory drugs in Russia Abstract PDF
(Rus)
Oleynikova T.A., Pozhidaeva D.N.
No 7-8 (2020) Analysis of foreign experience in training personnelfor the pharmaceutical industry in the European Union Abstract PDF
(Rus)
Budenkova E.A., Litvinova T.M.
No 4 (2019) ANALYSIS OF PATENT PORTFOLIOS IN THE ANTI-INFLUENZA DRUG SEGMENT Abstract PDF
(Rus)
Vyukhin M., Rodnin A., Shulgin V.
No 12 (2018) Analysis of patent portfolios of anticancer drugs Abstract PDF
(Rus)
Viukhin M., Shulgin V., Bushueva M.
No 11-12 (2020) Analysis of performance indicators of the High-cost Nosologies program in the constituent entities of the Russian Federation Abstract PDF
(Rus)
Petrukhina I.K., Yagudina R.I., Ryazanova T.K., Gladunova E.P., Egorova A.V., Khusainova A.I., Blinkova P.R., Loginova L.V.
No 7-8 (2019) Analysis of the drug assortment for palliative care for children in the Russian Federation Abstract PDF
(Rus)
Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Vrubel E.T.
No 13S (2018) Analysis of the FFP Tender Market in 2017 Abstract PDF
(Rus)
Article E.
No 7-8 (2020) Analysis of the market of products based on plant-based raw materials used in urology Abstract PDF
(Rus)
Safonova N.V., Trofimova E.O.
No 10 (2019) Analysis of the Russian paediatric antibacterials market Abstract PDF
(Rus)
Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Ladut'ko Y.M., Terninko T.M., Zagalov D.E., Mikhaylova Y.V.
No 3 (2021) Andrey DANILOV: «Khronicheskaya bol' – eto uzhe ne epidemiya, a pandemiya» Abstract PDF
(Rus)
- -.
No 1-3 (2020) Andrey Danilov: «Ser'eznoy problemoy ostaetsya pravil'noe ponimanie prirody khronicheskoy boli» Abstract PDF
(Rus)
Article E.
No 11-12 (2020) Anticoagulant group tender review Abstract PDF
(Rus)
Kalinina N.
No 4-6 (2020) Antipsychotic drugs market: issues of regional procurement Abstract PDF
(Rus)
Prozherina Y.
No 10 (2020) AnviMax®: optimal drug to combat ARVI and influenza Abstract PDF
(Rus)
Kalinina N.
No 1 (2022) Application of the ATC/DDD methodology in predicting the need for genetically engineered biological products used to treat patients with rheumatic diseases in a hospital setting Abstract
Ugoltsova V.N., Shakirova D.K., Abdulganieva D.I., Safiullin R.S.
No 11 (2018) Armais Kamalov: «Segodnya ochen' vazhno sfokusirovat' vnimanie na aktivnom dolgoletii muzhchin» Abstract PDF
(Rus)
Article E.
No 4 (2018) Artificial intelligence in health care: the system problems Abstract PDF
(Rus)
Kolesnichenko O.Y., Kolesnichenko Y.Y., Litvak D...
No 1-3 (2020) Assessing the relationship between deviations from GMP requirements and potential quality defects of medicinal products:a survey of employees of the pharmaceutical inspectorate Abstract PDF
(Rus)
Orlov V.A., Shestakov V.N.
No 1 (2022) Assessment of problems in the organization of day hospitals Abstract
Fayzullina R.N., Gilmanov A.A., Iskandarov I.R.
No 1 (2022) Assortment analysis of the pharmaceutical online market of over-the-counter drugs for external use in thermal burns Abstract
Lukoyanova I.E., Egorova S.N.
No 2 (2021) Atrial fibrillation: key aspects of therapy and place of DOAC Abstract PDF
(Rus)
Prozherina Y.
No 11 (2019) Bayer v dialoge s rossiyskimi spetsialistami zdravookhraneniya Abstract PDF
(Rus)
Article E.
No 7-8 (2020) Beyond the Future Abstract PDF
(Rus)
Prozherina Y.
No 12 (2019) Big Data Analytics of EHRs: pathogenic relations of cancer with Ischaemic Heart Disease and Diabetes Mellitus Abstract PDF
(Rus)
Kolesnichenko O.Y., Kolesnichenko Y.Y., Pulit V.V., Martynov A.V., Sotnik A.Y., Khaykina I.A., Marochkina E.B., Minushkina L.O., Pimenova K.V., Bugakova A.S., Vasilyeva E.Y., Komarov R.N., Golovanov A.V.
No 4 (2021) Biocompatible drugs-protectors against radiation exposure: a modern view on the problem Abstract
Khabriev R.U., Mingazova E.N., Sidorov V.V., Gureev S.A., Yusupova M.M.
No 3 (2021) Biosimilars: evolution of approaches to the development, regulation, life cycle control and interchangeability management Abstract PDF
(Rus)
Niyazov R.R., Dranitsyna M.A., Vasiliev A.N., Gavrishina E.V.
No 2 (2021) Biosimilars: reproduction of the clinical profile using modern biotechnology Abstract PDF
(Rus)
Niyazov R.R., Dranitsyna M.A., Vasiliev A.N., Gavrishina E.V.
No 1-2 (2019) Blood glucose meters and test strips: pharmacy market Abstract PDF
(Rus)
Prozherina J.
No 6 (2018) Brief review of judicial practice in the sphere of manufacturing and handling medical products for the period from february to May 2018 Abstract PDF
(Rus)
Borzova M.
No 1 (2022) Bringing registration dossiers in line with the requirements of the EAEU is the number one priority for pharmaceutical industry enterprises Abstract
Plotnikov A.V., Koroleva T.A.
No 9 (2020) Bronchial asthma: fundamental changes in the new GINA guidelines(2019) Abstract PDF
(Rus)
Vodovozov A.
No 13S (2018) Budget segment (exclusive of subsidized drug coverage) Abstract PDF
(Rus)
Article E.
No 12 (2019) Budget segment of the PD market in Russia: results for 9 months of 2019 Abstract PDF
(Rus)
Prozherina Y.
No 4 (2021) Building a logical-semantic model of the choice of fixed combinations of drugs for treatment of hypertension Abstract
Ibragimova G.Y., Fedotova A.A., Iksanova G.R., Khasanova R.Y., Vasilchenko K.A.
No 4 (2018) Business activity of medical industry enterprises: net profit rating 2016 Abstract PDF
(Rus)
Romanova S.
No 4 (2018) Business efficiency of enterprises in the pharmaceutical industry: net profit rating for 2016 Abstract PDF
(Rus)
Romanova S.
No 4 (2018) Business efficiency of enterprises in the pharmaceutical industry: net profit rating for 2016 Abstract PDF
(Rus)
Romanova S.
No 5 (2018) Business efficiency of enterprises in the pharmaceutical sector: 2016 net profit rating Abstract PDF
(Rus)
Romanova S.
No 3 (2018) Business efficiency of enterprises in the pharmaceutical sector: 2016 return on investment rating Abstract PDF
(Rus)
Romanova S.
No 1-2 (2018) Business efficiency of enterprises in the pharmaceutical sector: sales profit rating for 2016 Abstract PDF
(Rus)
Romanova S.
No 6 (2018) Business efficiency of enterprises in the pharmaceutical sector: stock turnover rating for 2016 Abstract PDF
(Rus)
Romanova S.
No 1-2 (2018) Business performance of pharma industry enterprises: 2016 equity turnover rating Abstract PDF
(Rus)
Romanova S.
No 13S (2018) Cerebrolysin® is currently enjoying a new lease on life Abstract PDF
(Rus)
Prozherina J.
No 4 (2019) CHALLENGES AND ISSUES IN OPERATING PERSONNEL MANAGEMENT DURING THE IMPLEMENTATION OF PHARMACEUTICAL QUALITY SYSTEM Abstract PDF
(Rus)
SMIRNOV V.A., GORYACHKIN V.V., SHESTAKOV V.N., ABRAMOVICH R.A.
No 1-2 (2019) Changes in VED list: an opportunity that came true Abstract PDF
(Rus)
Prozherina J., Shirokova I.
No 7-8 (2020) Changing breast cancer prognosis Abstract PDF
(Rus)
Prozherina Y., Shirokova I.
No 11 (2018) Characterization of export prospect of domestic anti-influenza vaccines in Latin American countries and Carribeans Abstract PDF
(Rus)
Trukhin V.P., Narkevich I.A., Nacharova E.P., Uiba S.V., Basakina I.I.
No 3 (2019) Chelovek legche perenosit golod, chem poteryu sna. Interv'yu s Ol'goy Vorob'evoy Abstract PDF
(Rus)
Article E.
No 1-3 (2020) Chem opasna bessonnitsa i kak s ney borot'sya? Abstract PDF
(Rus)
Article E.
No 11 (2019) Chronic vein diseases: a pressing issue of our time Abstract PDF
(Rus)
Beregovykh R., Prozherina Y.
No 1-2 (2019) Classification issues of GMP-inspection deficiencies: regulatory practices Abstract PDF
(Rus)
Orlov V.A., Shestakov V.N.
No 9 (2018) Classification of the Republic of Sakha (Yakutia) municipal districts by level of pharmaceutical aid provided using mathematical methods Abstract PDF
(Rus)
Tarabukina S.M., Moshkova L.V.
No 11 (2018) Climacteric syndrome: issues in modern pharmacotherapy Abstract PDF
(Rus)
Prozherina J., Ilyukhina E.
No 1-2 (2019) clinical guidelines. history of creation and development in the Russian Federation and abroad Abstract PDF
(Rus)
Kovaleva M.Y., Sukhorukikh O.A.
No 11-12 (2020) Clinical trials in the Coronavirus era: management of risks Abstract PDF
(Rus)
Vodovozov A.
No 1-2 (2018) Collecting of organizations' tax debts from its executives: how and when? Abstract PDF
(Rus)
Lavrentieva A.
No 9 (2019) Combination of private and public interests in the legal regulation of gene technologies Abstract PDF
(Rus)
Mokhov А.А., Yavorskiy A.N.
No 10 (2020) Comorbid patient with non-alcoholic fatty liver disease Abstract PDF
(Rus)
Shirokova E.N.
No 10 (2020) Comparative analysis of business models of top pharmaceutical manufacturing companies: financial analysis Abstract PDF
(Rus)
Yasinskaya L.E.
No 9 (2020) Comparison and analysis of the fda approved orphane drugs register and the vital and essential drugs list of the Russian Federation Abstract PDF
(Rus)
Yurochkin D.S., Leshkevich A.A., Golant Z.M., Narkevich I.A.
No 7-8 (2018) Conceptual issues of the federal state supervision reform in the sphere of circulation of drugs Abstract PDF
(Rus)
Shevyrev D.N.
No 4 (2021) Conflict of interest in retail sales of medicines: raising an issue Abstract
Matveev A.G., Mezentseva E.S.
No 11 (2019) Construct validation and reliability analysis of a questionnaire to evaluate the factors influencing pharmacy staff's recommendation of over-the-counter drugs in Vietnam Abstract PDF
(Rus)
Tran V.D., Dorofeeva V.V., Lagutkina T.P.
No 12 (2019) Contract manufacturing and R&D: emerging trends for the global pharmaceutical market Abstract PDF
(Rus)
Prozherina Y.
No 3 (2018) Contribution of the european forum for good clinical practice to improvement of the clinical trial process in Russia and other post-soviet countries Abstract PDF
(Rus)
Kubar O.I.
No 11 (2018) Cough and cold combinations market: what do Russians choose? Abstract PDF
(Rus)
Prozherina J.
No 4-6 (2020) COVID-19 vaccine: seeking salvage Abstract PDF
(Rus)
Prozherina Y.
No 2 (2021) COVID-19: not by vaccine alone Abstract PDF
(Rus)
Gandel V.
No 1 (2021) CRA University - School of Clinical Trial Monitors: 10 years of success Abstract PDF
(Rus)
Semenov-Tyan-Shanskiy V.L., Bal’Tserovich A.S., Sazonova A.N., Loginovskaya O.A., Verbitskaya E.V., Malikova E.A., Kolbin A.S., Zvartau E.E., Pavlovich D.M.
No 1-3 (2020) Curbing the insomnia epidemic Abstract PDF
(Rus)
Prozherina Y.
No 3 (2019) Current state and prospects of the russian market for nonwovens and kits: surgical kits, medical ware, linen Abstract PDF
(Rus)
Vanin A.
No 13S (2018) Cursor: analytical Review of auctions for medicinal products the territory of Russia at year-end 2017 Abstract PDF
(Rus)
Article E.
No 7-8 (2019) Czech pharmacies: from the social role to marketing Abstract PDF
(Rus)
Prozherina Y.
No 13S (2018) Defeating Cancer: R-Pharm aligns itself with the world immunonocology and cellular therapy Abstract PDF
(Rus)
Article E.
No 1 (2021) Defeating stroke Abstract PDF
(Rus)
Prozherina Y.P.
No 9 (2019) Dementia drugs market analysis in Russia Abstract PDF
(Rus)
Trofimova Е.О., Izvekov N.V.
No 13S (2018) Demographic situation World market Abstract PDF
(Rus)
Article E.
1 - 100 of 561 Items 1 2 3 4 5 6 > >> 

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
National research Institute of public health named after N. A. Semashko

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies